College of American Pathologists
CAP Committees & Leadership CAP Calendar of Events Estore CAP Media Center CAP Foundation
 
About CAP    Career Center    Contact Us      
Search: Search
  [Advanced Search]  
 
CAP Home CAP Advocacy CAP Reference Resources and Publications CAP Education Programs CAP Accreditation and Laboratory Improvement CAP Members
CAP Home > Case of the Month > 2011 - Case Archives > Clinical Summary: Thyroid gland

2011—March Case of the Month

Posted March 25, 2011

CLINICAL SUMMARY: THYROID GLAND  

CAP Foundation March 2011 Online Case of the Month

View case with:
PC users: ImageScope
First-time use of ImageScope?
* Download (required)

Why use ImageScope?

ImageScope offers many additional features including:

• Ability to view multiple slides
  concurrently; synchronize
  panning/zooming.

• Facility to author annotations.

• Capability to run analysis
  algorithms, and display results.

• Modify image brightness,
  contrast, color balance,
  etc.

• Generally faster and more
  responsive.

MAC/PC Users: WebViewer

After reading the summary, try answering the three related multiple-choice questions below.

A 72-year-old woman with a prominent asymmetric goiter presents to her physician complaining of recent onset of hoarseness and neck pain. Received for intraoperative consultation is a “midline neck mass probably thyroid” measuring 6.0 cm x 4.0 cm x 5.0 cm with attached skeletal muscle. Noted on the cut surface was a fleshy tan mass with indistinct borders, firmly attached to muscle and containing zones of necrosis.

Archive Case and Diagnosis: This case first appeared as Performance Improvement Program in Surgical Pathology (PIP) 2008, Case 8, and is undifferentiated (anaplastic) carcinoma of thyroid.

Criteria for Diagnosis and Comments: This malignant neoplasm, with predominately spindled cells, is an undifferentiated (anaplastic) carcinoma of thyroid (UCT). The sections contain a tumor composed of sheets of intersecting fascicles of pleomorphic spindled and epithelioid cells which efface any evidence of thyroid parenchyma. Areas of coagulative necrosis, nuclear atypia and readily identifiable mitotic figures are noted. The cellular growth pattern and anatomic location are hints to the diagnosis; however, the differential diagnosis includes a number of entities listed in the above master list.

Approximately 2 - 5% of all thyroid carcinomas are undifferentiated carcinoma. This neoplasm is more prevalent in areas where goiter is endemic. The vast majority of patients are elderly with a mean age of 70 years. Unlike other thyroid gland neoplasms there is only a slight female predilection (male: female rate 1:1.1 to 1.2). Most patients present with a rapidly growing neck mass or a sudden enlargement of a long standing goiter. The onset of enlargement is often associated with concomitant hoarseness, vocal cord paralysis, dysphagia and pain. These tumors on occasion have been reported to produce granulocyte-stimulating factor resulting in leukocytosis. Due to the rapid and widely invasive nature of this neoplasm, at the time of presentation about half of the patients are inoperable and have regional lymph node or distant metastasis. Despite aggressive multimodality therapy most patients survive less than 1 year; mean survival is 4 - 6 months.

Although the histologic features of UCT are variable, pleomorphic, epithelioid, spindle and giant cells are quite commonly seen. Some tumors may be composed entirely of one cell type. Spindle cell type in particular mimics a variety of sarcomas. A variety of morphologic subtypes of UCT have been described: angiomatoid, osteoclastic, rhabdoid, lymphoepithelioma-like, paucicellular variant, carcinosarcoma, adenosquamous and squamous cell carcinoma. Coagulative necrosis is usually extensive and mitotic figures are easily identified. Frequently, UCT contains an intense neutrophilic inflammatory component with aggregates of neutrophils as well as areas of notable vascular proliferation. A noteworthy characteristic feature of UCT is the propensity for vascular permeation with tumor obliteration of the vascular lumina. In thoroughly sampled tumors it has been reported that residual areas of differentiated thyroid carcinoma were found in 50 - 90% of the UCTs. This observation along with reported findings of progressive increase in p53 staining from convention carcinoma to UCT (differentiated thyroid carcinoma papillary/follicular 10 - 15% vs. UCT 70%) suggests that UCT may arise via “dedifferentiation” of differentiated thyroid carcinoma.

Cytokeratin (40 - 100%) and epithelial membrane antigen (50%) are the most common positive “epithelial” markers in UCT although often only focally or in individual cells. Vimentin is positive in 50 - 100% of the tumors. Thyroglobulin and thyroid transcription factor (TTF-1) are usually negative except in residual differentiated carcinoma. Calcitonin, HMB-45, neuroendocrine markers and lymphoid markers are negative. Some tumors may show focal staining with factor VIII related antigens.

The differential diagnosis includes a variety of entities including the following: Angiosarcoma as a primary tumor of thyroid exists; however, there is some histologic and immunohistochemical staining overlap with UCT. The prognosis of the two entities is similar. Angiosarcomas of the thyroid are usually epithelioid and contain binucleate cells but rarely contain multinucleated giant cells. The diagnosis of angiosarcoma should only be applied when unequivocal evidence of endothelial differentiation is demonstrated (positive for CD 31, CD34 and factor VIII related antigens) however some angiosarcomas occasionally are cytokeratin positive.

Lymphoma usually shows less cellular cohesion and can readily be distinguished by immunohistochemistry and flow cytometric analysis.

Papillary carcinomas of thyroid have the conventional nuclear features of papillary carcinoma, stain positive for TTF-1 and thyroglobulin. These tumors lack the pleomorphic nuclei and pleomorphic cytoplasmic shapes and abundant mitotic figures seen in UCT.

Riedel thyroiditis is a densely sclerotic inflammatory process which causes the thyroid gland to become adherent to adjacent structures. However atypical mitoses, ghosted vessels with spindle cells and the presence of marked cellular pleomorphism are not present. A small biopsy could prove the task problematic, if not impossible, in distinguishing these two entities.

Supplementary Questions:
For each of the following, select the most likely diagnosis from the diagnostic set (an answer may be used once, more than once, or not at all).

Question Diagnostic Set
1. The finding of a sclerotic process involving the thyroid with bland nuclear features and lacking vascular occlusion by spindle cells is most compatible with this entity? A. Angiosarcoma
B. Malignant lymphoma
C. Papillary carcinoma
D. Riedel thyroiditis
E. Undifferentiated (anaplastic) carcinoma
2. Which entity shares overlap of immunohistochemical markers and clinical course with undifferentiated carcinoma and frequently is composed of epithelioid cells? A. Angiosarcoma
B. Malignant lymphoma
C. Papillary carcinoma
D. Riedel thyroiditis
E. Undifferentiated (anaplastic) carcinoma
3. Which of the above tumors is characterized by extensive vascular plugging with malignant spindled cells that shows the majority of which 70% positive staining with p53? A. Angiosarcoma
B. Malignant lymphoma
C. Papillary carcinoma
D. Riedel thyroiditis
E. Undifferentiated (anaplastic) carcinoma

References

  1. Carcangiu ML, Steeper T, Zampi G et al. Anaplastic Thyroid Carcinoma, A study of 70 Cases. Am J Clin Pathol. 1985; 83:135-158.
  2. Miettinen M, Franssila KO. Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma. Hum Path. 2000; 31:1139-1145.
  3. Ordonez NG, Baloch Z, Matias-Guiu X. Undifferentiated (anaplastic) carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, (eds) WHO Tumours of Endocrine Organs. IARC Press, Lyon, France; 2004.
  4. Wan SK, Chan JK, Tang SK. Paucicellular variant of anaplastic thyroid carcinoma: A mimic of Riedel thyroiditis. Am J Clin Pathol. 1996; 105:388-393.
  5. Yazawa S, Toshimori H, Nakatsuru K et al. Thyroid anaplastic carcinoma producing granulocyte-colony-stimulating factor and parathyroid hormone-related protein. Intern Med. 1995; 34:584-588.

Author:
2008
Tihana Rumboldt, MD
Surgical Pathology Fellow
Medical University of South Carolina
Charleston SC

Mary S. Richardson, MD
Surgical Pathology Committee
Medical University of South Carolina
Charleston SC
 
 © 2014 College of American Pathologists. All rights reserved. | Terms and Conditions | CAP ConnectFollow Us on FacebookFollow Us on LinkedInFollow Us on TwitterFollow Us on YouTubeFollow Us on FlickrSubscribe to a CAP RSS Feed